Key UDI Projections in the EU
Ortho-Clinical Diagnostics, Eucomed UDI Task Force, GS1 Global and Endologix discuss the European UDI landscape for medical devices. As the medical device indu...
Executive Abstract
As the medical device industry awaits the finalised regulations from the EU, some have looked at the FDA and predicted that the EU is likely to mirror the preferences of the US body.
In this exclusive eBook, three UDI experts discuss the European landscape for medical devices. The interview panel is made up of Andrew Rutter, Senior Regulatory Affairs Associate for Ortho-Clinical Diagnostics and Chair of the Eucomed UDI Task Force, Geraldine Lissalde-Bonnet, Senior Public Policy Manager for Healthcare at GS1 Global Office, and Dawn Fowler, Senior Manager for Global Labeling / Training at Endologix. The piece explores:
Unlock Report Access
Complete this brief form for instant PDF access.
Related Executive Research
White Paper
MasterControl Registrations for Medical Device
Registering new products in different countries is a time-consuming and nerve-wracking process. For medical device firms, the process is part of an intense per...
White Paper
The Definitive Guide to Data-Driven Compliance for Medical Device and Pharmaceutical Manufacturers
Key Pillars for Empowering Compliance Teams with Cloud-based Data and Analytics Chief Compliance Officers and teams are challenged with tracking and managing t...
Guide
FDA Readiness Toolkit for Medical Device Companies
Quality standards are defined by governing entities like the FDA in order to promote and sustain the quality of medical devices manufactured throughout the worl...